MDL Over Pfizer's Neurontin Soon To Be 46 Cases Lighter
Lawyers for hundreds of Neurontin multidistrict litigation plaintiffs, who accuse Pfizer Inc. of a fraudulent scheme to promote the anti-epilepsy drug for off-label use, have agreed to cut 46 cases from...To view the full article, register now.
Already a subscriber? Click here to view full article